Open an account

Zhengye Biotechnology Holding

ZYBT · NASDAQ

$1.47−$0.02 (−1.34%)TodayMarket open · · Delayed 15 min
Prev close $1.49

About ZYBT

Zhengye Biotechnology Holding Ltd. engages in the manufacture and sale of veterinary vaccines. The company is headquartered in Jilin, Jilin and currently employs 277 full-time employees. The company went IPO on 2025-01-07. The firm markets a diverse range of vaccines, including vaccines for swine, cattle, goats, sheep, poultry, and dogs. The firm owns about 44 veterinary vaccines in its product portfolio, which cover veterinary vaccines for livestock, including monovalent vaccine, polyvalent vaccine, combined vaccine and combined and polyvalent vaccine. The firm also engages in vaccines for treating livestock. The firm mainly conducts its business in the domestic market. The firm mainly conducts its business in the domestic and overseas market.

Employees
277
Headquarters
Jilin, Jilin
Listed
Jan 7, 2025
Sector
Health Care
Industry
Pharmaceuticals
Website
ir.jlzybio.com

ZYBT key statistics

Market cap
40.43M
Price-earnings ratio
—
Dividend yield
—
Average volume
3.45M
Volume
516
Open price
$1.43
High today
$1.49
Low today
$1.43
52 Week high
$8.01
52 Week low
$0.6155

Zhengye Biotechnology Holding (ZYBT) at a glance

Zhengye Biotechnology Holding (ZYBT) last traded at $1.47, with a market cap of 40.43M.

Today the stock has traded between $1.43 and $1.49. The current price is 2.8% above the day's low and 1.0% below its high.

Volume so far is 516 shares, below the average of 3.45M shares a day.

Over the past year Zhengye Biotechnology Holding has ranged from $0.6155 to $8.01, and now sits 12% of the way up that range.

ZYBT news

  • 12 Health Care Stocks Moving In Thursday's Pre-Market Session

  • 12 Health Care Stocks Moving In Wednesday's After-Market Session

  • 12 Health Care Stocks Moving In Wednesday's Intraday Session

  • 12 Health Care Stocks Moving In Thursday's Intraday Session

  • 12 Health Care Stocks Moving In Thursday's Pre-Market Session

  • 12 Health Care Stocks Moving In Wednesday's After-Market Session

  • Akanksha Bakshi

    Zhengye Biotechnology Stock Plunges Following 322% Rally In Volatile Reversal

  • Avi Kapoor

    Dow Surges 300 Points; General Motors Posts Upbeat Earnings

Similar companies

Companies in the same industry as Zhengye Biotechnology Holding

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.